Baillie Gifford & Co
MDT icon

Baillie Gifford & Co’s Medtronic MDT Stock Holding History

Baillie Gifford & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3M Buy
463,954
+6,610
+1% +$533K 0.03% 166
2026
Q1 		$39.6M Sell
457,344
-17,730
-4% -$1.7M 0.04% 157
2025
Q4 		$45.6M Sell
475,074
-3,140
-0.7% -$305K 0.04% 153
2025
Q3 		$45.5M Sell
478,214
-14,640
-3% -$1.35M 0.03% 157
2025
Q2 		$43M Sell
492,854
-12,274
-2% -$1.04M 0.03% 157
2025
Q1 		$45.4M Sell
505,128
-12,252
-2% -$1.1M 0.04% 147
2024
Q4 		$41.3M Sell
517,380
-14,922
-3% -$1.29M 0.03% 152
2024
Q3 		$47.9M Buy
532,302
+99,747
+23% +$8.39M 0.04% 145
2024
Q2 		$34M Sell
432,555
-40,100
-8% -$3.29M 0.03% 157
2024
Q1 		$41.2M Sell
472,655
-6,089
-1% -$520K 0.03% 153
2023
Q4 		$39.4M Buy
478,744
+6,606
+1% +$503K 0.03% 165
2023
Q3 		$37M Sell
472,138
-6,307
-1% -$528K 0.03% 162
2023
Q2 		$42.2M Buy
478,445
+14,356
+3% +$1.24M 0.04% 161
2023
Q1 		$37.4M Buy
464,089
+28,444
+7% +$2.32M 0.03% 161
2022
Q4 		$33.9M Buy
435,645
+4,599
+1% +$373K 0.04% 164
2022
Q3 		$34.8M Buy
431,046
+9,901
+2% +$890K 0.04% 162
2022
Q2 		$37.8M Buy
421,145
+51,765
+14% +$5.24M 0.04% 166
2022
Q1 		$41M Buy
369,380
+22,292
+6% +$2.36M 0.03% 183
2021
Q4 		$35.9M Buy
347,088
+33,608
+11% +$3.89M 0.02% 201
2021
Q3 		$39.3M Buy
313,480
+7,914
+3% +$1.02M 0.02% 200
2021
Q2 		$37.9M Buy
305,566
+7,536
+3% +$946K 0.02% 204
2021
Q1 		$35.2M Buy
298,030
+89,283
+43% +$10.5M 0.02% 201
2020
Q4 		$24.5M Sell
208,747
-140
-0.1% -$15.4K 0.01% 191
2020
Q3 		$21.7M Buy
208,887
+3,334
+2% +$335K 0.01% 179
2020
Q2 		$18.8M Buy
+205,553
New +$19.7M 0.01% 172

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Baillie Gifford & Co's MDT Position: Q2 2026 in Review

Baillie Gifford & Co increased its Medtronic (MDT) stake by 1.4% in Q2 2026, buying an estimated $533K and bringing the position to 463,954 shares worth $36.3M. The position accounts for 0.03% of the portfolio, ranked #166.

Baillie Gifford & Co first reported a position in MDT in Q2 2020 and has held it in 25 quarters since. The position peaked at $47.9M in Q3 2024. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Baillie Gifford & Co held 463,954 shares of Medtronic worth $36.3M as of Q2 2026.
  • Baillie Gifford & Co bought 6,610 Medtronic shares in Q2 2026, an estimated $533K.
  • Medtronic made up 0.03% of Baillie Gifford & Co's portfolio in Q2 2026, its #166 holding.
  • Baillie Gifford & Co first reported a position in Medtronic in Q2 2020 and has held it in 25 quarters since.
  • Baillie Gifford & Co's Medtronic position peaked at $47.9M in Q3 2024.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.